The evidence leans constructive7 supporting, 1 against, 0 worth knowing
Supporting
trading 4% above its 200-day average
up 1% over twelve months
matches long tail above — rejected higher, which has beaten the market by +0.39 points over 20 sessions across 16,308 past signals
2 of the scans it matches have a positive measured record
5 independent kinds of evidence agree today, which is uncommon
revenue grew 38% year on year in the quarter ending 2026-06-30
net margin has widened from 2.3% to 4.5% across four quarters
Against
3 of the scans it matches have historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close below 1,451, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working3
Net profit +544.2% year on year, Rs 8 cr to Rs 50 cr.
+544.2%Rs 8 crRs 50 cr
Revenue +44.5% year on year, Rs 774 cr to Rs 1,118 cr.
+44.5%Rs 774 crRs 1,118 cr
Profit grew faster than revenue, +544.2% against +44.5%.
+544.2%+44.5%
Needs watching
Nothing in the filings stands out either way.
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
12 of 47 matched on 2026-08-21
VENKEYS matches 12 of the 47 scans today, across 5 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
segments and revenue mix, as the company reports them
VENKEYS reports 3 business segments. The largest is Oilseed at 46% of revenue in the quarter ending 2026-06-30.
SegmentRevenueSharevs a year ago
Oilseed528 cr45.6%—
Poultry and Poultry Products517 cr44.6%—
Animal Health Products114 cr9.8%—
Segment names are the company’s own, taken verbatim from the reportable-segment disclosure in its quarterly XBRL filing. Nothing on this page describes the business in words we wrote.
Quality of the business
balance sheet as at 2026-03-31
Return on equity
13.5%
trailing profit over shareholders’ funds
Return on capital
16.8%
pre-tax profit over equity plus borrowings
Debt to equity
0.10×
163 cr borrowed against 1,596 cr of equity
Net debt
101 cr
borrowings less cash
Cash conversion
89%
operating cash flow as a share of profit
Receivable days
49
how long customers take to pay
Return on capital uses profit before tax over equity plus borrowings. The textbook version adds finance costs back; those are not tagged reliably in quarterly filings, so this understates the ratio for a heavily borrowed company rather than flattering it. Balance sheets are filed half-yearly, so these can be up to six months behind the profit figures above.
Valuation against its own history
500 sessions since 2024-09-06
12×
median 16×
24×
now 10×
VENKEYS trades at 10× trailing earnings, below its median of 16× over this window — 37% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Results filings were typically -0.52pt vs the market over the next 5 sessions (n=7,520) · Board meeting filings were typically -0.04pt vs the market over the next 5 sessions (n=5,458)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 38% against the same quarter a year earlier
revenue rose in 4 of the last 4 quarters
Going against it
profit dropped 34% year on year
net margin narrowed from 8.8% to 4.5%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · standalone
1,118
69
50
35.49
4.5%
Q4 FY26
2026-03-31 · standalone
1,100
133
97
71.96
8.8%
Q3 FY26
2025-12-31 · standalone
960
66
49
34.48
5.1%
Q3 FY25
2024-12-31 · standalone
882
28
20
14.47
2.3%
Q2 FY25
2024-09-30 · standalone
774
11
8
5.51
1.0%
Q1 FY25
2024-06-30 · standalone
808
101
75
53.36
9.3%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+1.6%
Versus 200-day average+3.9%
Below 52-week high-11.8%
Above 52-week low+28.7%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)34.5
Higher closes in last 52 of 5
Six-month return+11.25%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.90%
Volume versus 20-day0.2x
Median daily turnoverRs 5.5 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.